Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus

Table 2

SLEDAI Score in the initial ​ ​and at the end of the last cycle of RTX.

(a)  

Patient	SLEDAI score
	Beginning	End
1	40	0
2	8	0
3	14	0
4	18	2
5	14	0
6	8	2
7	18	0
8	8	0
9	7	0
10	11	0
11	8	0
12	14	0
13	22	2
14	14	0
15	6	0
16	22	4
17	11	0
18	9	0

(b)  

	Beginning	End	𝑃 value
Score	12.5 (8–18)	0 (0-0)	𝑃=0.0002